Large international pharmaceutical companies, including Pfizer, Lilly, Abbvie, Sanofi and MSD, decided to suspend new clinical studies in Russia, report “Vedomosti”.
Representatives of organizations called the cause of termination of the test situation around Ukraine.
According to information, the American enterprise Pfizer intends to transfer all clinical trials outside Russia.
According to the publication, foreign pharmaceutical companies have not yet filed official requests for early termination of clinical studies of their medicinal drugs in Russia. At the moment it is not known how long international organizations will not conduct research on the territory of Russia.